Sassine Andy's Form 4/A amendment
AmendedArcturus Therapeutics Holdings Inc. (ARCT) · filed Aug 20, 2025
- Accession no.
- 0001193805-25-001215
- Filed
- Aug 20, 2025
- Trade date
- Aug 15, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 19, 2025
This filing lists 1 non-derivative transaction. Open-market purchases total $20.5K. It was filed 5 days after the trade.
This amendment replaces 0001193805-25-001212 (filed Aug 19, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sassine AndyCIK 0001515322 | Director, Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Common Stock | PPurchaseAcquired | +1,238 | $16.56F2 | +$20,501.28 | 221,764 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The purchase reported on this Form 4 was effected by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the "ESPP").
- F2
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2025.
Referenced by the price of 1 transaction in Table I.